Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Berrino

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Cancers|June 14, 2020
Pazopanib and Trametinib as a Synergistic Strategy against Osteosarcoma: Preclinical Activity and Molecular InsightsGiulia Chiabotto, Giovanni Grignani, Maja Todorovic, et al.
International Journal of Molecular Sciences|September 23, 2022
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GISTErika Fiorino, Alessandra Merlini, Lorenzo D'Ambrosio, et al.
Pathologica|September 18, 2025
Part I - Pre-analytical phaseCaterina Marchiò, Enrico Berrino, Stefania Scarpino, et al.
ESMO Open|October 30, 2020
MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancerAnnalisa Petrelli, Sara Erika Bellomo, Ivana Sarotto, et al.
Frontiers in Oncology|September 16, 2022
DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combinationAlessandra Merlini, Maria Laura Centomo, Giulio Ferrero, et al.
Journal of Translational Medicine|January 6, 2024
Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer CentresMatteo Pallocca, Ivan Molineris, Enrico Berrino, et al.
Nature Medicine|August 1, 2022
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trialAndrea Sartore-Bianchi, Filippo Pietrantonio, Sara Lonardi, et al.
Cells|February 21, 2020
<i>PIK3R1</i><sup>W624R</sup> Is an Actionable Mutation in High Grade Serous Ovarian CarcinomaConcetta D'Ambrosio, Jessica Erriquez, Maddalena Arigoni, et al.
The American Journal of Surgical Pathology|July 6, 2018
The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for TreatmentCaterina Marchiò, Patrizia Dell'Orto, Laura Annaratone, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 23, 2023
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanomaLidia Giraudo, Giulia Cattaneo, Loretta Gammaitoni, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Cancers|June 14, 2020
Pazopanib and Trametinib as a Synergistic Strategy against Osteosarcoma: Preclinical Activity and Molecular InsightsGiulia Chiabotto, Giovanni Grignani, Maja Todorovic, et al.
International Journal of Molecular Sciences|September 23, 2022
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GISTErika Fiorino, Alessandra Merlini, Lorenzo D'Ambrosio, et al.
Pathologica|September 18, 2025
Part I - Pre-analytical phaseCaterina Marchiò, Enrico Berrino, Stefania Scarpino, et al.
ESMO Open|October 30, 2020
MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancerAnnalisa Petrelli, Sara Erika Bellomo, Ivana Sarotto, et al.
Frontiers in Oncology|September 16, 2022
DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combinationAlessandra Merlini, Maria Laura Centomo, Giulio Ferrero, et al.
Journal of Translational Medicine|January 6, 2024
Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer CentresMatteo Pallocca, Ivan Molineris, Enrico Berrino, et al.
Nature Medicine|August 1, 2022
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trialAndrea Sartore-Bianchi, Filippo Pietrantonio, Sara Lonardi, et al.
Cells|February 21, 2020
<i>PIK3R1</i><sup>W624R</sup> Is an Actionable Mutation in High Grade Serous Ovarian CarcinomaConcetta D'Ambrosio, Jessica Erriquez, Maddalena Arigoni, et al.
The American Journal of Surgical Pathology|July 6, 2018
The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for TreatmentCaterina Marchiò, Patrizia Dell'Orto, Laura Annaratone, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 23, 2023
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanomaLidia Giraudo, Giulia Cattaneo, Loretta Gammaitoni, et al.
Pageof 6